Search

everythinglearnresearchcommunity

for

Search:↓

The Cyp11a1 gene variation has a weak link to PCOS, but higher di-hydro-testosterone levels are found in PCOS patients.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

CTP-543 is generally safe for treating alopecia areata.

Antiandrogen treatment helps reduce hair follicles and sebaceous glands in hirsute women.

GI197111X is best dissolved in Capmul MCM for trials.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

MitoQ helps protect hair cells from damage in hair loss by boosting a protective enzyme.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Ozenoxacin reduces sebum production, helping manage acne.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Estrogen alone can lower testosterone in some transfeminine people.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.